Published in

Esmo Open, Esmo Open, 1(8), p. 101394, 2023

DOI: 10.1016/j.esmoop.2023.101394

Links

Tools

Export citation

Search in Google Scholar

205P VERITAC update: Phase II study of ARV-471, a PROteolysis TArgeting Chimera (PROTAC) estrogen receptor (ER) degrader in ER+/human epidermal growth factor receptor 2 (HER2)- advanced breast cancer

Journal article published in 2023 by S. A. Hurvitz, A. Schott, C. X. Ma, R. Nanda, G. Zahrah, N. Hunter, A. Tan, M. L. Telli, J. Anampa, R. Jeselsohn, P. Munster, E. Zhi, R. Gedrich, C. Mather, H. Han and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload
Policy details
Data provided by SHERPA/RoMEO